BGM Group Ltd is a Cayman Islands-based holding company that operates in China's pharmaceutical and chemical industries through contractual arrangements with Gansu Qilianshan Pharmaceutical Co., Ltd. and its subsidiaries. The company manufactures and sells a diversified portfolio of pharmaceutical ingredients and finished products (including oxytetracycline, licorice extracts, heparin sodium, and traditional Chinese herbal medicines), fertilizer products designed for agricultural use, and specialty food items like natural sausage casings, primarily serving pharmaceutical manufacturers, medical preparation companies, agricultural producers, and food industry customers in China. The company generates revenue through manufacturing and distribution of these pharmaceutical, agricultural, and food products via its subsidiaries, with financial results consolidated as the primary beneficiary of the VIE structure.